![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/495 | |
A61P 3/10 |
(11) | Number of the document | 1505977 |
(13) | Kind of document | T |
(96) | European patent application number | 03755446.6 |
Date of filing the European patent application | 2003-05-21 | |
(97) | Date of publication of the European application | 2005-02-16 |
(45) | Date of publication and mention of the grant of the patent | 2014-09-10 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2003/016277 |
Date | 2003-05-21 |
(87) | Number | WO 2003/099281 |
Date | 2003-12-04 |
(30) | Number | Date | Country code |
382781 P | 2002-05-21 | US | |
459332 P | 2003-03-31 | US |
(72) |
WOLFF, Andrew, US
JERLING, Markus, SE
|
(73) |
Gilead Sciences, Inc.,
333 Lakeside Drive, Foster City, CA 94404,
US
|
(54) | ADMINISTRATION OF A PARTIAL FATTY ACID OXIDATION INHIBITOR SUCH AS RANOLAZINE FOR THE TREATMENT OF DIABETES |
ADMINISTRATION OF A PARTIAL FATTY ACID OXIDATION INHIBITOR SUCH AS RANOLAZINE FOR THE TREATMENT OF DIABETES |